{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:18:10Z","timestamp":1774678690316,"version":"3.50.1"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.6898-25","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:10:26Z","timestamp":1774303826000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Arginine Vasopressin Deficiency with Anti-rabphilin-3A Antibody Positivity Following an Influenza Infection"],"prefix":"10.2169","author":[{"given":"Yuki","family":"Nakada","sequence":"first","affiliation":[{"name":"Division of Diabetes, Metabolism and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamagata","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Sugimura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, School of Medicine, Fujita Health University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Tasso","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takefumi","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, School of Medicine, Fujita Health University, Japan"},{"name":"Department of Endocrinology and Diabetes, Daido Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, School of Medicine, Fujita Health University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, School of Medicine, Fujita Health University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shojiro","family":"Sawada","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tomkins M, Lawless S, Martin-Grace J, Sherlock M, Thompson CJ. Diagnosis and management of central diabetes insipidus in adults. J Clin Endocrinol Metab 107: 2701-2715, 2022.","DOI":"10.1210\/clinem\/dgac381"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Imura H, Nakao K, Shimatsu A, et al. Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. N Engl J Med 329: 683-689, 1993.","DOI":"10.1056\/NEJM199309023291002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR. Autoimmune hypophysitis. Endocr Rev 26: 599-614, 2005.","DOI":"10.1210\/er.2004-0011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Iwama S, Sugimura Y, Kiyota A, et al. Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis. J Clin Endocrinol Metab 100: E946-954, 2015.","DOI":"10.1210\/jc.2014-4209"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kume Y, Sakuma H, Sekine H, Sumikoshi M, Sugimura Y, Hosoya M. Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus. Clin Pediatr Endocrinol 30: 65-69, 2021.","DOI":"10.1297\/cpe.30.65"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rajevac H, Bachan M, Khan Z. Diabetes insipidus as a symptom of COVID-19 infection: case report. Chest 158: A2576, 2020.","DOI":"10.1016\/j.chest.2020.09.172"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sheikh AB, Javed N, Sheikh AAE, Upadhyay S, Shekhar R. Diabetes insipidus and concomitant myocarditis: A late sequelae of COVID-19 infection. J Investig Med High Impact Case Rep 9: 2324709621999954, 2021.","DOI":"10.1177\/2324709621999954"},{"key":"8","unstructured":"8. Sheikh AB, Javaid MA, Sheikh AAE, Shekhar R. Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report. Pan Afr Med J 38: 222, 2021."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Misgar RA, Rasool A, Wani AI, Bashir MI. Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection. J Endocrinol Invest 44: 2855-2856, 2021.","DOI":"10.1007\/s40618-021-01627-z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yavari A, Sharifan Z, Larijani B, Mosadegh Khah AM. Central diabetes insipidus secondary to COVID-19 infection: a case report. BMC Endocr Disord 22: 134, 2022.","DOI":"10.1186\/s12902-022-01048-w"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lizzi M, Aric\u00f2 M, Carlone G, Anzellotti MT, Trotta D, Palatino V. Central diabetes insipidus: another rare complication of SARS-CoV-2 infection in children?. Pediatr Infect Dis J 41: e448, 2022.","DOI":"10.1097\/INF.0000000000003632"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Suresh Kumar SS, Kumar K, Venkataramani S, Ghazi NM. Central diabetes insipidus: an acute manifestation of COVID-19 infection. Cureus 15: e43884, 2023.","DOI":"10.7759\/cureus.43884"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zerrouki D, Assarrar I, Rami I, Rouf S, Latrech H. Coronavirus as a trigger of lymphocytic hypophysitis in an adolescent girl: an exceptional case report. Int J Surg Case Rep 115: 109218, 2024.","DOI":"10.1016\/j.ijscr.2023.109218"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Natsuki Y, Nagata Y, Nagasaki T, et al. A case of central diabetes insipidus after COVID-19 as a probable diagnosis of lymphocytic infundibulo-neurohypophysitis with positive anti-rabphilin-3A antibodies with review of literature. Endocr J 71: 1165-1173, 2024.","DOI":"10.1507\/endocrj.EJ24-0093"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Medeiros RS, Neves L, Sousa I, Pereira BD. Arginine-vasopressin deficiency due to long COVID-associated infundibulo-neurohypophysitis. Arch Endocrinol Metab 68: e240168, 2025.","DOI":"10.20945\/2359-4292-2024-0168"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kobayashi T, Miwa T, Odawara M. A case of central diabetes insipidus following probable type A\/H1N1 influenza infection. Endocr J 58: 913-918, 2011.","DOI":"10.1507\/endocrj.EJ11-0029"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Pajvani U, Lipton ML, Grajower MM. Diabetes insipidus associated with hemophagocytic lymphohistiocytosis: first case report. Endocr Pract 17: e118-e122, 2011.","DOI":"10.4158\/EP10409.CR"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wang J, Stewart E, Dapaah-Afriyie K, Finn A. Mild encephalopathy with reversible splenial lesion in a patient with influenza A infection--first report in an adult patient in the USA. BMJ Case Rep 2015: bcr2015210197, 2015.","DOI":"10.1136\/bcr-2015-210197"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Murai A, Shinojima N, Ikuta G, et al. Two children with lymphocytic hypophysitis presenting with positive anti-rabphilin-3A antibody. Endocr J 70: 703-709, 2023.","DOI":"10.1507\/endocrj.EJ22-0637"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Takizawa H, Goto H, Uchida T, et al. Arginine vasopressin deficiency onset after COVID-19 vaccination with positive anti-rabphilin-3A antibodies: a case report and literature review. BMC Endocr Disord 24: 143, 2024.","DOI":"10.1186\/s12902-024-01664-8"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yasuda Y, Iwama S, Kiyota A, et al. Critical role of rabphilin-3A in the pathophysiology of experimental lymphocytic neurohypophysitis. J Pathol 244: 469-478, 2018.","DOI":"10.1002\/path.5046"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ankireddypalli AR, Chow LS, Radulescu A, Kawakami Y, Araki T. A case of hypophysitis associated with SARS-CoV-2 vaccination. AACE Clin Case Rep 8: 204-209, 2022.","DOI":"10.1016\/j.aace.2022.06.001"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6898-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:24:49Z","timestamp":1774668289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6898-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6898-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"6898-25"}}